Fox Jonathan C - Mar 3, 2023 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director
Signature
/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
Stock symbol
EWTX
Transactions as of
Mar 3, 2023
Transactions value $
$0
Form type
4
Date filed
3/7/2023, 04:59 PM
Previous filing
Mar 7, 2023
Next filing
Jun 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Award $0 +43.7K $0.00 43.7K Mar 3, 2023 Common Stock 43.7K $9.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option vest each month beginning on March 3, 2023, subject to the Reporting Person continuing as a service provider through each vest date.